209 related articles for article (PubMed ID: 28894400)
21. Prevalence and Antibiotic Resistance of
Gajdács M; Urbán E
Health Serv Res Manag Epidemiol; 2019; 6():2333392819870774. PubMed ID: 31453265
[TBL] [Abstract][Full Text] [Related]
22. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.
Chang YT; Lin CY; Chen YH; Hsueh PR
Front Microbiol; 2015; 6():893. PubMed ID: 26388847
[TBL] [Abstract][Full Text] [Related]
23. Stenotrophomonas maltophilia in Malaysia: molecular epidemiology and trimethoprim-sulfamethoxazole resistance.
Neela V; Rankouhi SZ; van Belkum A; Goering RV; Awang R
Int J Infect Dis; 2012 Aug; 16(8):e603-7. PubMed ID: 22698885
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of antibiotic resistance and integrons,
Ebrahim-Saraie HS; Heidari H; Soltani B; Mardaneh J; Motamedifar M
Iran J Basic Med Sci; 2019 Aug; 22(8):872-877. PubMed ID: 31579442
[TBL] [Abstract][Full Text] [Related]
25. Emerging importance of multidrug-resistant Stenotrophomonas maltophilia infections in neonatal intensive care unit in a tertiary center in Turkey.
Demirbuğa A; Akgün Karapınar DB; Yaşa B; Çoban A; Öngen B; Dede E; Mete Atasever N; Somer A; Hançerli Törün S
Pediatr Neonatol; 2024 Mar; 65(2):183-187. PubMed ID: 37919104
[TBL] [Abstract][Full Text] [Related]
26. Severe cellulitis/myositis caused by Stenotrophomonas maltophilia.
Downhour NP; Petersen EA; Krueger TS; Tangella KV; Nix DE
Ann Pharmacother; 2002 Jan; 36(1):63-6. PubMed ID: 11816260
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial Susceptibility of
Gales AC; Seifert H; Gur D; Castanheira M; Jones RN; Sader HS
Open Forum Infect Dis; 2019 Mar; 6(Suppl 1):S34-S46. PubMed ID: 30895213
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.
Zelenitsky SA; Iacovides H; Ariano RE; Harding GK
Diagn Microbiol Infect Dis; 2005 Jan; 51(1):39-43. PubMed ID: 15629227
[TBL] [Abstract][Full Text] [Related]
29. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
[TBL] [Abstract][Full Text] [Related]
30.
Fukuda A; Usui M; Wakao H; Boonla C; Tamura Y
J Med Microbiol; 2017 Aug; 66(8):1202-1206. PubMed ID: 28771133
[No Abstract] [Full Text] [Related]
31. Successful Treatment of Persistent
Hsu AJ; Simner PJ; Bergman Y; Mathers AJ; Tamma PD
Open Forum Infect Dis; 2023 Apr; 10(4):ofad174. PubMed ID: 37125227
[No Abstract] [Full Text] [Related]
32. Epidemiological Trends and Resistance Associated with
Gajdács M; Urbán E
Diseases; 2019 May; 7(2):. PubMed ID: 31159258
[No Abstract] [Full Text] [Related]
33. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
[TBL] [Abstract][Full Text] [Related]
34. Distinct groups and antimicrobial resistance of clinical Stenotrophomonas maltophilia complex isolates from Korea.
Rhee JY; Choi JY; Choi MJ; Song JH; Peck KR; Ko KS
J Med Microbiol; 2013 May; 62(Pt 5):748-753. PubMed ID: 23429694
[TBL] [Abstract][Full Text] [Related]
35. Current Situation of Antimicrobial Resistance and Genetic Differences in Stenotrophomonas maltophilia Complex Isolates by Multilocus Variable Number of Tandem Repeat Analysis.
Rhee JY; Song JH; Ko KS
Infect Chemother; 2016 Dec; 48(4):285-293. PubMed ID: 28032486
[TBL] [Abstract][Full Text] [Related]
36.
Hamdi AM; Fida M; Abu Saleh OM; Beam E
Open Forum Infect Dis; 2020 Jan; 7(1):ofaa008. PubMed ID: 32016126
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.
Church D; Lloyd T; Peirano G; Pitout J
Scand J Infect Dis; 2013 Apr; 45(4):265-70. PubMed ID: 23113657
[TBL] [Abstract][Full Text] [Related]
38.
Flamm RK; Shortridge D; Castanheira M; Sader HS; Pfaller MA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427295
[TBL] [Abstract][Full Text] [Related]
39. Trimethoprim-sulfamethoxazole versus levofloxacin for the treatment of Stenotrophomonas maltophilia infections: A multicentre cohort study.
Almangour TA; Alkherb Z; Alruwaite S; Alsahli R; Alali H; Almohaizeie A; Almuhisen S; Alowais SA; Saleh KB; Fetyani L; Alnashmi F; Alghofaily A; Abouobaid NI; Binkhamis KM; Tawfik EA; Alsowaida YS
J Glob Antimicrob Resist; 2024 May; 38():42-48. PubMed ID: 38821443
[TBL] [Abstract][Full Text] [Related]
40. Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI.
Kumar S; Bandyopadhyay M; Chatterjee M; Banerjee P; Poddar S; Banerjee D
Adv Biomed Res; 2015; 4():36. PubMed ID: 25789262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
